www.veristat.com
Open in
urlscan Pro
199.60.103.254
Public Scan
Submitted URL: https://clicktime.symantec.com/15tTDwKTdkNArDMUCiQAM?h=n7r1sos_VpllzqTmnk-fHAKtNWfkXjcd3RaE-XhAcOQ=&u=https://www.veristat.com/...
Effective URL: https://www.veristat.com/blog
Submission: On August 29 via api from IL — Scanned from SE
Effective URL: https://www.veristat.com/blog
Submission: On August 29 via api from IL — Scanned from SE
Form analysis 1 forms found in the DOM
POST https://forms.hsforms.com/submissions/v3/public/submit/formsnext/multipart/1333476/0ebd54d0-8d59-4b71-86c0-9eb241f76a0d
<form id="hsForm_0ebd54d0-8d59-4b71-86c0-9eb241f76a0d_5006" method="POST" accept-charset="UTF-8" enctype="multipart/form-data" novalidate=""
action="https://forms.hsforms.com/submissions/v3/public/submit/formsnext/multipart/1333476/0ebd54d0-8d59-4b71-86c0-9eb241f76a0d"
class="hs-form-private hsForm_0ebd54d0-8d59-4b71-86c0-9eb241f76a0d hs-form-0ebd54d0-8d59-4b71-86c0-9eb241f76a0d hs-form-0ebd54d0-8d59-4b71-86c0-9eb241f76a0d_d90ec910-6ff3-4fcb-8409-e0717c0ecad1 hs-form stacked hs-custom-form"
target="target_iframe_0ebd54d0-8d59-4b71-86c0-9eb241f76a0d_5006" data-instance-id="d90ec910-6ff3-4fcb-8409-e0717c0ecad1" data-form-id="0ebd54d0-8d59-4b71-86c0-9eb241f76a0d" data-portal-id="1333476">
<div class="hs_email hs-email hs-fieldtype-text field hs-form-field"><label id="label-email-0ebd54d0-8d59-4b71-86c0-9eb241f76a0d_5006" class="" placeholder="Enter your Email"
for="email-0ebd54d0-8d59-4b71-86c0-9eb241f76a0d_5006"><span>Email</span><span class="hs-form-required">*</span></label>
<legend class="hs-field-desc" style="display: none;"></legend>
<div class="input"><input id="email-0ebd54d0-8d59-4b71-86c0-9eb241f76a0d_5006" name="email" required="" placeholder="" type="email" class="hs-input" inputmode="email" autocomplete="email" value=""></div>
</div>
<div class="hs_blog_news_and_events_subscription hs-blog_news_and_events_subscription hs-fieldtype-radio field hs-form-field" style="display: none;"><label id="label-blog_news_and_events_subscription-0ebd54d0-8d59-4b71-86c0-9eb241f76a0d_5006"
class="" placeholder="Enter your Notification Frequency" for="blog_news_and_events_subscription-0ebd54d0-8d59-4b71-86c0-9eb241f76a0d_5006"><span>Notification Frequency</span></label>
<legend class="hs-field-desc" style="display: none;"></legend>
<div class="input"><input name="blog_news_and_events_subscription" class="hs-input" type="hidden" value="instant"></div>
</div>
<div class="hs_submit hs-submit">
<div class="hs-field-desc" style="display: none;"></div>
<div class="actions"><input type="submit" class="hs-button primary large" value="Subscribe"></div>
</div><input name="hs_context" type="hidden"
value="{"embedAtTimestamp":"1693327507106","formDefinitionUpdatedAt":"1661957236454","userAgent":"Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.110 Safari/537.36","pageTitle":"Blog | Veristat Insightful Perspectives","pageUrl":"https://www.veristat.com/blog","pageId":"4404275155","isHubSpotCmsGeneratedPage":true,"canonicalUrl":"https://www.veristat.com/blog","contentType":"listing-page","hutk":"e0ca8397b26290103d194400d84eeb7c","__hsfp":4036121453,"__hssc":"196217779.1.1693327508151","__hstc":"196217779.e0ca8397b26290103d194400d84eeb7c.1693327508150.1693327508150.1693327508150.1","formTarget":"#hs_form_target_form_333954832","formInstanceId":"5006","rawInlineMessage":"Thanks for subscribing to our newsletters.","hsFormKey":"733451e5616f2cfb28dabc950ed20445","locale":"en","timestamp":1693327508185,"originalEmbedContext":{"portalId":"1333476","formId":"0ebd54d0-8d59-4b71-86c0-9eb241f76a0d","region":"na1","target":"#hs_form_target_form_333954832","isBuilder":false,"isTestPage":false,"isPreview":false,"formInstanceId":"5006","formsBaseUrl":"/_hcms/forms","css":"","inlineMessage":"Thanks for subscribing to our newsletters.","isMobileResponsive":true,"rawInlineMessage":"Thanks for subscribing to our newsletters.","hsFormKey":"733451e5616f2cfb28dabc950ed20445","pageId":"4404275155","contentType":"listing-page","formData":{"cssClass":"hs-form stacked hs-custom-form"},"isCMSModuleEmbed":true},"correlationId":"d90ec910-6ff3-4fcb-8409-e0717c0ecad1","renderedFieldsIds":["email","blog_news_and_events_subscription"],"captchaStatus":"NOT_APPLICABLE","emailResubscribeStatus":"NOT_APPLICABLE","isInsideCrossOriginFrame":false,"source":"forms-embed-1.3611","sourceName":"forms-embed","sourceVersion":"1.3611","sourceVersionMajor":"1","sourceVersionMinor":"3611","_debug_allPageIds":{"embedContextPageId":"4404275155","analyticsPageId":"67220893345","pageContextPageId":"67220893345"},"_debug_embedLogLines":[{"clientTimestamp":1693327507210,"level":"INFO","message":"Retrieved customer callbacks used on embed context: [\"getExtraMetaDataBeforeSubmit\"]"},{"clientTimestamp":1693327507210,"level":"INFO","message":"Retrieved pageContext values which may be overriden by the embed context: {\"pageTitle\":\"Blog | Veristat Insightful Perspectives\",\"pageUrl\":\"https://www.veristat.com/blog\",\"userAgent\":\"Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/116.0.5845.110 Safari/537.36\",\"pageId\":\"67220893345\",\"isHubSpotCmsGeneratedPage\":true}"},{"clientTimestamp":1693327507212,"level":"INFO","message":"Retrieved countryCode property from normalized embed definition response: \"SE\""},{"clientTimestamp":1693327508171,"level":"INFO","message":"Retrieved analytics values from API response which may be overriden by the embed context: {\"hutk\":\"e0ca8397b26290103d194400d84eeb7c\",\"canonicalUrl\":\"https://www.veristat.com/blog\",\"contentType\":\"listing-page\",\"pageId\":\"67220893345\"}"}]}"><iframe
name="target_iframe_0ebd54d0-8d59-4b71-86c0-9eb241f76a0d_5006" style="display: none;"></iframe>
</form>Text Content
We use cookies to improve your user experience, remember your preferences
support website function and analyse website traffic. For this reason, we may
share your site usage date with our analytics partners. By clicking “Accept,”
you consent to store on your device all technologies described in our Cookie
Policy.
Select Your Cookie Preferences
Accept All Cookies Decline
* CAREERS
* EVENTS
* LIBRARY
* NEWS
* Why Veristat
* About Us
* Our Approach
* Our Leadership
* Success Stories
* News
* Locations
* Careers
* Open Positions
* Core Values
* Explore Benefits
* Grow Your Career
* Because We Care
* Why Veristat
* Therapeutic Areas
* Oncology
* Infectious Disease
* Endocrine/Metabolic
* CNS/Neurology
* Cardiovascular Disease
* Coronavirus
* More Therapy Areas
* Solutions
* Rare Diseases
* Decentralized Trials
* Rescue Trials
* Full Service
* Clinical Trial Planning
* Clinical Trial Conduct
* Regulatory Submission
* Cell and Gene Therapies
* Natural History Trials
* Vaccine Trials
* Services
* Strategic Consulting
* Adaptive Designs
* Regulatory Affairs
* Regulatory Consulting
* Marketing Applications
* Chemistry, Manufacturing, and Controls (CMC)
* Agency Meetings
* Regulatory Publishing
* Medical Devices/IVDs
* Clinical Operations
* Project Management
* Monitoring & Site Management
* Patient Recruitment
* Patient Retention & Site Engagement
* Medical Affairs
* Clinical Trial Safety
* Data Review Committees
* Medical Monitoring
* Medical Writing
* Biometrics
* Data Management
* Biostatistics
* Statistical Programming
* Standards Implementation
* Pharmacovigilance
* Resourcing/FSP
* Knowledge Base
* Library
* Blog
* Webinars
* Podcasts
* Success Stories
* Newsletter
* Contact Us
* RFP
* Why Veristat Toggle Menu
* About Us
* Our Approach
* Our Leadership
* Success Stories
* News
* Locations
* Careers Toggle Menu
* Open Positions
* Core Values
* Explore Benefits
* Grow Your Career
* Because We Care
* Why Veristat
* Therapeutic Areas Toggle Menu
* Oncology
* Infectious Disease
* Endocrine/Metabolic
* CNS/Neurology
* Cardiovascular Disease
* Coronavirus
* More Therapy Areas
* Solutions Toggle Menu
* Rare Diseases
* Decentralized Trials
* Rescue Trials
* Full Service Toggle Menu
* Clinical Trial Planning
* Clinical Trial Conduct
* Regulatory Submission
* Cell and Gene Therapies
* Natural History Trials
* Vaccine Trials
* Services Toggle Menu
* Strategic Consulting Toggle Menu
* Adaptive Designs
* Regulatory Affairs Toggle Menu
* Regulatory Consulting
* Marketing Applications
* Chemistry, Manufacturing, and Controls (CMC)
* Agency Meetings
* Regulatory Publishing
* Medical Devices/IVDs
* Clinical Operations Toggle Menu
* Project Management
* Monitoring & Site Management
* Patient Recruitment
* Patient Retention & Site Engagement
* Medical Affairs Toggle Menu
* Clinical Trial Safety
* Data Review Committees
* Medical Monitoring
* Medical Writing
* Biometrics Toggle Menu
* Data Management
* Biostatistics
* Statistical Programming
* Standards Implementation
* Pharmacovigilance
* Resourcing/FSP
* Knowledge Base Toggle Menu
* Library
* Blog
* Webinars
* Podcasts
* Success Stories
* Newsletter
* Contact Us
* RFP
BLOG | THINK SCIENTIFIC
GAIN THE LATEST INSIGHTS AND TRENDS IN CLINICAL TRIALS, PATIENT RECRUITMENT,
DATA ANALYSIS, ADAPTIVE DESIGN, REGULATORY SUBMISSIONS AND APPROVALS.
Filter by Tag All Regulatory Consulting Regulatory Submissions Clinical Trial
Regulations COVID-19 Featured Clinical Trials Talent & Culture Life At Veristat
Events Strategic Consulting Success Stories Project Management Clinical
Operations/Monitoring full-service Data Management Medical Writing marketing
applications Adaptive Design Site Engagement Stats & Programming Therapeutic
Areas of Expertise Virtual Trials decentralized trials oncology webinar cell
therapy gene therapy biologics biometrics Patient Retenttion Podcast case study
SIGN UP TODAY
Email*
Notification Frequency
4 min read
REGULATORY GUIDANCE MONTHLY REVIEW - JULY 2023
August 22, 2023
Each month, Veristat's regulatory team tracks and shares a selection of new
Regulatory Guidance updates from the US Food & Drug Administration (FDA) that
are pertinent to the governance of clinical trials and drug, biologic, or
medical device development...
READ MORE
1 min read
UNLOCKING INSIGHTS: THE IMPACT OF NEW MEDICAL DEVICE EU REGULATION (MDR)
August 15, 2023
Veristat and TOPRA recently hosted an informative webinar on the topic of the
impact of new EU regulations on the development of medical devices and drug
combination products. The European Commission's adoption of Regulation (EU)
READ MORE
1 min read
BIOSIMILAR FDA MEETING TYPES
August 8, 2023
It is crucial for biosimilar developers to engage early and often with FDA to
ensure the health authority is well-informed and supports your planned
development path. Regulatory meetings and interactions provide sponsors the
opportunity to receive...
READ MORE
2 min read
STRENGTHENING OPPORTUNITIES FOR GROWTH IN THE EUROPEAN REGION
July 27, 2023
With the recent changes in clinical trial regulations and the growth of clinical
trials in Europe, Veristat continues to build its footprint in the European
region. Veristat’s VP of Europe, Montserrat Barcélo Riera, recently spoke to
Annelot Huijgen of...
READ MORE
2 min read
ON-DEMAND WEBINAR: SINGLE-ARM STUDIES FOR USE AS A REGISTRATIONAL STUDY IN
ONCOLOGY
July 14, 2023
Single-arm clinical trials are gaining attention as potential registrational
studies in oncology research. This webinar provides an overview of single-arm
trials, their foundations for registration, and regulatory strategies associated
with the US...
READ MORE
3 min read
REGULATORY GUIDANCE MONTHLY REVIEW - JUNE 2023
July 6, 2023
Each month, Veristat's regulatory team tracks and shares a selection of new
Regulatory Guidance updates from the US Food & Drug Administration (FDA) that
are pertinent to the governance of clinical trials and drug, biologic, or
medical device development...
READ MORE
THE INFLUENCE OF MDR’S ARTICLE 117 IN THE MARKETING OF COMBINATION PRODUCTS
July 5, 2023
The European Union Medical Device Regulation’s (MDR) Article 117 brings improved
patient safety measures with new implications for manufacturers, as they must
fulfill a significant set of additional requirements.
READ MORE
1 min read
MIGRATION OF DATA BETWEEN EDCS
June 28, 2023
Factors such as ongoing industry consolidation, continual regulatory change,
rapid technology evolution, and unending cost-cutting are causing organizations
to consider replacing or upgrading their existing Electronic Data Capture (EDC)
solution.
READ MORE
1 min read
SUCCESSFUL FULL-SERVICE, RANDOMIZED PANCREATIC CANCER PHASE II TRIAL
June 22, 2023
Learn how Veristat’s multidisciplinary team was able to work with the sponsor to
solve challenges across numerous areas of this full-service phase II cancer
trial. Collaborative efforts led to the sponsor decided not to close the Phase
II study upon the...
READ MORE
2 min read
HOW DOES REAL-WORLD EVIDENCE IMPACT MEDICINAL PRODUCT DEVELOPMENT IN EUROPE?
June 21, 2023
Explore the growing role of Real-World Evidence (RWE) in the regulatory
decision-making process for medicinal products in Europe. Learn how RWE is
reshaping the development landscape, its potential benefits, and the challenges
associated with its...
READ MORE
1 2 3 4 5 Next
WHY VERISTAT?
Why Veristat?
* About Us
* Our Approach
* Our Leadership
* Success Stories
* News
* Locations
* Careers
THERAPEUTIC AREAS
Therapeutic Areas
* Oncology
* Infectious Disease
* Endocrine/Metabolic
* CNS/Neurology
* Coronavirus
* Cardiovascular Disease
* More Therapy Areas
SOLUTIONS
Solutions
* Rare Diseases
* Decentralized Trials
* Rescue Trials
* Full Service
* Strategic Resourcing
* Cell and Gene Therapies
* Vaccine Trials
* Natural History Trials
SERVICES
Services
* Strategic Consulting
* Regulatory Affairs
* Clinical Operations
* Medical Affairs
* Medical Writing
* Biometrics
* Pharmacovigilance
* Resourcing/FSP
* Privacy Policy
© 2023 Veristat, LLC. All rights reserved. Veristat is a trademark of Veristat,
LLC. All other trademarks are the property of their respective owners.
FacebookTwitterLinkedIn
Return to Top